Deutsche Bank downgraded Alvotech (ALVO) to Hold from Buy with a price target of $8, down from $14, after the company received a complete response letter from the FDA for AVT05. The CRL noted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results